EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis

Anna-Polina Shurygina iD, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva iD, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna-Polina Shurygina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis is a major global threat to human health. Since the widely used BCG vaccine is poorly effective in adults, there is a demand for the development of a new type of boost tuberculosis vaccine. We designed a novel intranasal tuberculosis vaccine candidate, TB/FLU-04L, which is based on an attenuated influenza A virus vector encoding two mycobacterium antigens, Ag85A and ESAT-6. As tuberculosis is an airborne disease, the ability to induce mucosal immunity is one of the potential advantages of influenza vectors. Sequences of ESAT-6 and Ag85A antigens were inserted into the NS1 open reading frame of the influenza A virus to replace the deleted carboxyl part of the NS1 protein. The vector expressing chimeric NS1 protein appeared to be genetically stable and replication-deficient in mice and non-human primates. Intranasal immunization of C57BL/6 mice or cynomolgus macaques with the TB/FLU-04L vaccine candidate induced Mtb-specific Th1 immune response. Single TB/FLU-04L immunization in mice showed commensurate levels of protection in comparison to BCG and significantly increased the protective effect of BCG when applied in a “prime-boost” scheme. Our findings show that intranasal immunization with the TB/FLU-04L vaccine, which carries two mycobacterium antigens, is safe, and induces a protective immune response against virulent M. tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanTuberculosisMycobacterium tuberculosisTuberculosis VaccinesAdultMiceHumansAnimalsBCG VaccineAntigens, BacterialMice, Inbred C57BLBacterial ProteinsAcyltransferases

Stichwörter der Autor:innen

Ag85AESAT-6M. tuberculosis vaccineinfluenza vectormucosal immunization

Substanzen

BCG VaccineAntigens, BacterialInfluenza VaccinesTuberculosis VaccinesBacterial ProteinsAcyltransferases

Autor:innen und Institutionen

  • Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197022 St. Petersburg, Russia.
  • Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Health of the Russian Federation, 191036 St. Petersburg, Russia.
  • Research Institute for Biological Safety Problems, Gvardeiskiy 080409, Kazakhstan.

ORCID-Profile: Anna-Polina Shurygina, Gulbanu Sarsenbayeva

Förderung

  • Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan

Zitieren

APA

Shurygina, A. P., Zabolotnykh, N., Vinogradova, T., Khairullin, B., Kassenov, M., Nurpeisova, A., Sarsenbayeva, G., Sansyzbay, A., Vasilyev, K., Buzitskaya, J., Egorov, A., & Stukova, M. (2023). Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087439

Vancouver

Shurygina AP, Zabolotnykh N, Vinogradova T, Khairullin B, Kassenov M, Nurpeisova A, et al. Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087439

BibTeX
@article{Shurygina2023,
  author = {Shurygina, Anna-Polina and Zabolotnykh, Natalia and Vinogradova, Tatiana and Khairullin, Berik and Kassenov, Markhabat and Nurpeisova, Ainur and Sarsenbayeva, Gulbanu and Sansyzbay, Abylai and Vasilyev, Kirill and Buzitskaya, Janna and Egorov, Andrey and Stukova, Marina},
  title = {Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087439}
}
Kostenlos starten →